<VariationArchive RecordType="classified" VariationID="953494" VariationName="NM_033629.6(TREX1):c.23dup (p.Pro10fs)" VariationType="Duplication" Accession="VCV000953494" Version="6" NumberOfSubmissions="4" NumberOfSubmitters="3" DateLastUpdated="2023-08-06" DateCreated="2020-07-16" MostRecentSubmission="2023-02-07">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="943590" VariationID="953494">
      <GeneList>
        <Gene Symbol="ATRIP" FullName="ATR interacting protein" GeneID="84126" HGNC_ID="HGNC:33499" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>3p21.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="48446737" stop="48467645" display_start="48446737" display_stop="48467645" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="48488113" stop="48507053" display_start="48488113" display_stop="48507053" Strand="+" />
          </Location>
          <OMIM>606605</OMIM>
        </Gene>
        <Gene Symbol="ATRIP-TREX1" FullName="ATRIP-TREX1 readthrough" GeneID="111822955" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>3p21.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="48446779" stop="48467645" display_start="48446779" display_stop="48467645" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="TREX1" FullName="three prime repair exonuclease 1" GeneID="11277" HGNC_ID="HGNC:12269" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>3p21.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="48465830" stop="48467645" display_start="48465830" display_stop="48467645" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="48506918" stop="48509043" display_start="48506918" display_stop="48509043" Strand="+" />
          </Location>
          <OMIM>606609</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_033629.6(TREX1):c.23dup (p.Pro10fs)</Name>
      <CanonicalSPDI>NC_000003.12:48466673:CCCCC:CCCCCC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>3p21.31</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="48466673" stop="48466674" display_start="48466673" display_stop="48466674" variantLength="1" positionVCF="48466673" referenceAlleleVCF="G" alternateAlleleVCF="GC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="48508072" stop="48508073" display_start="48508072" display_stop="48508073" variantLength="1" positionVCF="48508072" referenceAlleleVCF="G" alternateAlleleVCF="GC" />
      </Location>
      <ProteinChange>P10fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_282" sequenceAccession="LRG_282">
            <Expression>LRG_282:g.5849dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_282t1" sequenceAccession="LRG_282t1">
            <Expression>LRG_282t1:c.23dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_282p1" sequenceAccession="LRG_282p1" change="p.Pro10fs">
            <Expression>LRG_282p1:p.Pro10fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_033629.2" sequenceAccession="NM_033629" sequenceVersion="2" change="c.23dup">
            <Expression>NM_033629.2:c.23dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.48508077dup" Assembly="GRCh37">
            <Expression>NC_000003.11:g.48508077dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.48466678dup" Assembly="GRCh38">
            <Expression>NC_000003.12:g.48466678dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009820.2" sequenceAccession="NG_009820" sequenceVersion="2" change="g.5849dup">
            <Expression>NG_009820.2:g.5849dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_033100.1" sequenceAccession="NG_033100" sequenceVersion="1" change="g.39187dup">
            <Expression>NG_033100.1:g.39187dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_041782.1" sequenceAccession="NG_041782" sequenceVersion="1" change="g.24969dup">
            <Expression>NG_041782.1:g.24969dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_153405.1" sequenceAccession="NR_153405" sequenceVersion="1" change="n.3332dup">
            <Expression>NR_153405.1:n.3332dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_007248.5" sequenceAccession="NM_007248" sequenceVersion="5" change="c.-8dup">
            <Expression>NM_007248.5:c.-8dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_033629.6" sequenceAccession="NM_033629" sequenceVersion="6" change="c.23dup" MANESelect="true">
            <Expression>NM_033629.6:c.23dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_338599.1" sequenceAccession="NP_338599" sequenceVersion="1" change="p.Pro10fs">
            <Expression>NP_338599.1:p.Pro10fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001271023.2" sequenceAccession="NM_001271023" sequenceVersion="2" change="c.*1124dup">
            <Expression>NM_001271023.2:c.*1124dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001624" Type="3 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_032166.4" sequenceAccession="NM_032166" sequenceVersion="4" change="c.*1124dup">
            <Expression>NM_032166.4:c.*1124dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001624" Type="3 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_130384.3" sequenceAccession="NM_130384" sequenceVersion="3" change="c.*1124dup" MANESelect="true">
            <Expression>NM_130384.3:c.*1124dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001624" Type="3 prime UTR variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="781731683" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_033629.6(TREX1):c.23dup (p.Pro10fs) AND multiple conditions" Accession="RCV001225792" Version="3">
        <ClassifiedConditionList TraitSetID="12753">
          <ClassifiedCondition DB="MedGen" ID="C0796126">Aicardi-Goutieres syndrome 1</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0024145">Chilblain lupus 1</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1860518">Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-10-27" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_033629.6(TREX1):c.23dup (p.Pro10fs) AND Aicardi-Goutieres syndrome 1" Accession="RCV001291770" Version="1">
        <ClassifiedConditionList TraitSetID="1148">
          <ClassifiedCondition DB="MedGen" ID="C0796126">Aicardi-Goutieres syndrome 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-05-04" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_033629.6(TREX1):c.23dup (p.Pro10fs) AND Chilblain lupus 1" Accession="RCV001291771" Version="1">
        <ClassifiedConditionList TraitSetID="1150">
          <ClassifiedCondition DB="MedGen" ID="C0024145">Chilblain lupus 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-05-04" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_033629.6(TREX1):c.23dup (p.Pro10fs) AND not provided" Accession="RCV002462846" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="CN517202">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-05-13" SubmissionCount="1">Uncertain significance</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-10-27" NumberOfSubmissions="4" NumberOfSubmitters="3" DateCreated="2020-07-16" MostRecentSubmission="2023-02-07">
        <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
        <Description>Conflicting classifications of pathogenicity</Description>
        <Explanation DataSource="ClinVar" Type="public">Pathogenic(1); Likely pathogenic(2); Uncertain significance(1)</Explanation>
        <Citation Type="general">
          <ID Source="PubMed">24183309</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25582466</ID>
        </Citation>
        <Comment DataSource="ClinVar" Type="public">Pathogenic(1); Likely pathogenic(2); Uncertain significance(1)</Comment>
        <DescriptionHistory Dated="2022-12-01">
          <Description>Pathogenic/Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2021-02-19">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="12753" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="141" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">CREE ENCEPHALITIS</ElementValue>
                <XRef Type="MIM" ID="225750" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Aicardi-Goutieres syndrome 1</ElementValue>
                <XRef ID="MONDO:0009165" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ENCEPHALOPATHY, FAMILIAL INFANTILE, WITH INTRACRANIAL CALCIFICATION AND CHRONIC CEREBROSPINAL FLUID LYMPHOCYTOSIS</ElementValue>
                <XRef Type="MIM" ID="225750" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PSEUDOTOXOPLASMOSIS SYNDROME</ElementValue>
                <XRef Type="MIM" ID="225750" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">AGS</ElementValue>
                <XRef Type="MIM" ID="225750" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">AGS1</ElementValue>
                <XRef Type="MIM" ID="225750" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Most characteristically, Aicardi-Goutières syndrome (AGS) manifests as an early-onset encephalopathy that usually, but not always, results in severe intellectual and physical disability. A subgroup of infants with AGS present at birth with abnormal neurologic findings, hepatosplenomegaly, elevated liver enzymes, and thrombocytopenia, a picture highly suggestive of congenital infection. Otherwise, most affected infants present at variable times after the first few weeks of life, frequently after a period of apparently normal development. Typically, they demonstrate the subacute onset of a severe encephalopathy characterized by extreme irritability, intermittent sterile pyrexias, loss of skills, and slowing of head growth. Over time, as many as 40% develop chilblain skin lesions on the fingers, toes, and ears. It is becoming apparent that atypical, sometimes milder, cases of AGS exist, and thus the true extent of the phenotype associated with pathogenic variants in the AGS-related genes is not yet known.</Attribute>
                <XRef ID="NBK1475" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10893" />
                <XRef ID="10893" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301648</ID>
                <ID Source="BookShelf">NBK1475</ID>
              </Citation>
              <XRef ID="51" DB="Orphanet" />
              <XRef ID="C0796126" DB="MedGen" />
              <XRef ID="MONDO:0009165" DB="MONDO" />
              <XRef Type="MIM" ID="225750" DB="OMIM" />
            </Trait>
            <Trait ID="1425" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Chilblain lupus 1</ElementValue>
                <XRef ID="MONDO:0012500" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CHBL1</ElementValue>
                <XRef Type="MIM" ID="610448" DB="OMIM" />
              </Symbol>
              <XRef ID="C0024145" DB="MedGen" />
              <XRef ID="MONDO:0012500" DB="MONDO" />
              <XRef Type="MIM" ID="610448" DB="OMIM" />
            </Trait>
            <Trait ID="6104" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Cerebroretinal vasculopathy, hereditary</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Retinopathy, vascular, with cerebral and renal involvement and Raynaud and migraine phenomena</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations</ElementValue>
                <XRef ID="MONDO:0008641" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Vasculopathy, retinal, with cerebral leukodystrophy</ElementValue>
                <XRef ID="Vasculopathy%2C+retinal%2C+with+cerebral+leukodystrophy/7360" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">RVCLS</ElementValue>
                <XRef Type="MIM" ID="192315" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CRV</ElementValue>
                <XRef Type="MIM" ID="192315" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">RVCL</ElementValue>
                <XRef ID="GTR000553865" DB="Genetic Testing Registry (GTR)" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">TREX1-Related Retinal Vasculopathy with Cerebral Leukoencephalopathy and Systemic Manifestations</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations (RVCL-S) is a small-vessel disease that affects highly vascularized tissues including the retina, brain, liver, and kidneys. Age of onset is often between 35 and 50 years. The most common presenting finding is decreased visual acuity and/or visual field defects. Neurologic manifestations may include hemiparesis, facial weakness, aphasia, and hemianopsia. Migraines and seizures are less frequently described. Renal manifestations may include mild-to-moderate increase in serum creatinine and mild proteinuria; progression to end-stage renal disease (ESRD) is uncommon. Hepatic manifestations frequently include mildly elevated levels of alkaline phosphatase and gamma-glutamyltransferase (GGT). Less common findings include psychiatric disorders, hypertension, mild-to-moderate anemia, and Raynaud phenomenon.</Attribute>
                <XRef ID="NBK546576" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">31536185</ID>
                <ID Source="BookShelf">NBK546576</ID>
              </Citation>
              <XRef ID="247691" DB="Orphanet" />
              <XRef ID="3421" DB="Orphanet" />
              <XRef ID="63261" DB="Orphanet" />
              <XRef ID="71291" DB="Orphanet" />
              <XRef ID="C1860518" DB="MedGen" />
              <XRef ID="MONDO:0008641" DB="MONDO" />
              <XRef Type="MIM" ID="192315" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1148" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="141" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">CREE ENCEPHALITIS</ElementValue>
                <XRef Type="MIM" ID="225750" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Aicardi-Goutieres syndrome 1</ElementValue>
                <XRef ID="MONDO:0009165" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ENCEPHALOPATHY, FAMILIAL INFANTILE, WITH INTRACRANIAL CALCIFICATION AND CHRONIC CEREBROSPINAL FLUID LYMPHOCYTOSIS</ElementValue>
                <XRef Type="MIM" ID="225750" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PSEUDOTOXOPLASMOSIS SYNDROME</ElementValue>
                <XRef Type="MIM" ID="225750" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">AGS</ElementValue>
                <XRef Type="MIM" ID="225750" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">AGS1</ElementValue>
                <XRef Type="MIM" ID="225750" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Most characteristically, Aicardi-Goutières syndrome (AGS) manifests as an early-onset encephalopathy that usually, but not always, results in severe intellectual and physical disability. A subgroup of infants with AGS present at birth with abnormal neurologic findings, hepatosplenomegaly, elevated liver enzymes, and thrombocytopenia, a picture highly suggestive of congenital infection. Otherwise, most affected infants present at variable times after the first few weeks of life, frequently after a period of apparently normal development. Typically, they demonstrate the subacute onset of a severe encephalopathy characterized by extreme irritability, intermittent sterile pyrexias, loss of skills, and slowing of head growth. Over time, as many as 40% develop chilblain skin lesions on the fingers, toes, and ears. It is becoming apparent that atypical, sometimes milder, cases of AGS exist, and thus the true extent of the phenotype associated with pathogenic variants in the AGS-related genes is not yet known.</Attribute>
                <XRef ID="NBK1475" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10893" />
                <XRef ID="10893" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301648</ID>
                <ID Source="BookShelf">NBK1475</ID>
              </Citation>
              <XRef ID="51" DB="Orphanet" />
              <XRef ID="C0796126" DB="MedGen" />
              <XRef ID="MONDO:0009165" DB="MONDO" />
              <XRef Type="MIM" ID="225750" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1150" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1425" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Chilblain lupus 1</ElementValue>
                <XRef ID="MONDO:0012500" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CHBL1</ElementValue>
                <XRef Type="MIM" ID="610448" DB="OMIM" />
              </Symbol>
              <XRef ID="C0024145" DB="MedGen" />
              <XRef ID="MONDO:0012500" DB="MONDO" />
              <XRef Type="MIM" ID="610448" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Developmental Genetics Unit, King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="CN517202" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2917377" SubmissionDate="2021-02-05" DateLastUpdated="2021-02-20" DateCreated="2021-02-20">
        <ClinVarSubmissionID localKey="NM_033629.6:c.23dup_1" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV001480387" DateUpdated="2021-02-20" DateCreated="2021-02-20" Type="SCV" Version="1" SubmitterName="New York Genome Center" OrgID="507558" OrganizationCategory="laboratory" OrgAbbreviation="NYGC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-05-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>The c.23dup (p.Pro10AlafsTer92) variant identified in the TREX1 gene is a single nucleotide duplication resulting in a frameshift of the protein at amino acid 10/315 (coding exon 2/2). This is predicted to lead to the premature termination of the protein approximately 92 amino acids downstream of the variant. This variant is absent from gnomAD (v3.0) suggesting it is not a common benign variant in the populations represented in this database. This variant is absent from ClinVar and to our current knowledge has not been reported in affected individuals in the literature, although frameshift and nonsense variants downstream have been reported in both autosomal recessive and autosomal dominant TREX1 associated disorders (PMID:25731743; PMID:25604658; PMID:31130681). Given its deleterious nature and absence in population databases, the c.23dup (p.Pro10AlafsTer92) variant identified in the TREX1 gene is reported here as Likely Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">NYGC Assertion Criteria 2020</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/hhfhf6ms/nygc_assertion_criteria_2020.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <NamePlatform>NovaSeq 6000</NamePlatform>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="TestName">whole genome sequencing</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="NumberMosaic" integerValue="0" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SecondaryFinding">no</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0002015" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0006530" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0000717" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0005352" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_033629.6:c.23dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="225750" Type="MIM" />
          </Trait>
        </TraitSet>
        <StudyName>CSER-NYCKidSeq</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB9039564</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2917378" SubmissionDate="2021-02-05" DateLastUpdated="2021-02-20" DateCreated="2021-02-20">
        <ClinVarSubmissionID localKey="NM_033629.6:c.23dup_2" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV001480388" DateUpdated="2021-02-20" DateCreated="2021-02-20" Type="SCV" Version="1" SubmitterName="New York Genome Center" OrgID="507558" OrganizationCategory="laboratory" OrgAbbreviation="NYGC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-05-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>The c.23dup (p.Pro10AlafsTer92) variant identified in the TREX1 gene is a single nucleotide duplication resulting in a frameshift of the protein at amino acid 10/315 (coding exon 2/2). This is predicted to lead to the premature termination of the protein approximately 92 amino acids downstream of the variant. This variant is absent from gnomAD (v3.0) suggesting it is not a common benign variant in the populations represented in this database. This variant is absent from ClinVar and to our current knowledge has not been reported in affected individuals in the literature, although frameshift and nonsense variants downstream have been reported in both autosomal recessive and autosomal dominant TREX1 associated disorders (PMID:25731743; PMID:25604658; PMID:31130681). Given its deleterious nature and absence in population databases, the c.23dup (p.Pro10AlafsTer92) variant identified in the TREX1 gene is reported here as Likely Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">NYGC Assertion Criteria 2020</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/hhfhf6ms/nygc_assertion_criteria_2020.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <NamePlatform>NovaSeq 6000</NamePlatform>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="TestName">whole genome sequencing</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="NumberMosaic" integerValue="0" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SecondaryFinding">no</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0002015" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0006530" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0000717" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0005352" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_033629.6:c.23dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="610448" Type="MIM" />
          </Trait>
        </TraitSet>
        <StudyName>CSER-NYCKidSeq</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB9039564</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5392246" SubmissionDate="2022-11-30" DateLastUpdated="2022-12-03" DateCreated="2022-12-03">
        <ClinVarSubmissionID localKey="GDXSV:249589" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002757319" DateUpdated="2022-12-03" DateCreated="2022-12-03" Type="SCV" Version="1" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Comment>Frameshift variant predicted to result in protein truncation, as the last 305 amino acids are replaced with 91 different amino acids, and other loss-of-function variants have been reported downstream in HGMD; Has not been previously published as pathogenic or benign to our knowledge</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TREX1" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:6021171</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_033629.2:c.23dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_147_20221130054204</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2733048" SubmissionDate="2023-01-10" DateLastUpdated="2023-02-07" DateCreated="2020-07-16">
        <ClinVarSubmissionID localKey="1540702|MedGen:C1860518;C0796126;C0024145" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001398084" DateUpdated="2023-02-07" DateCreated="2020-07-16" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-10-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">24183309</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25582466</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Pro10Alafs*92) in the TREX1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 305 amino acid(s) of the TREX1 protein. This variant is present in population databases (rs781731683, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with TREX1-related conditions. ClinVar contains an entry for this variant (Variation ID: 953494). This variant disrupts a region of the TREX1 protein in which other variant(s) (p.Cys99Metfs*3) have been determined to be pathogenic (PMID: 24183309, 25582466). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TREX1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000003.11:g.48508072_48508073insC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1860518" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0796126" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0024145" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8755776</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2917378" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002015" MappingRef="HP">
        <MedGen CUI="C0011168" Name="Dysphagia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2917378" TraitType="Disease" MappingType="XRef" MappingValue="610448" MappingRef="OMIM">
        <MedGen CUI="C0024145" Name="Chilblain lupus 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2917378" TraitType="Finding" MappingType="XRef" MappingValue="HP:0006530" MappingRef="HP">
        <MedGen CUI="C5441745" Name="Abnormal pulmonary interstitial morphology" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2733048" TraitType="Disease" MappingType="XRef" MappingValue="C0024145" MappingRef="MedGen">
        <MedGen CUI="C0024145" Name="Chilblain lupus 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5392246" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="CN517202" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2917377" TraitType="Finding" MappingType="XRef" MappingValue="HP:0006530" MappingRef="HP">
        <MedGen CUI="C5441745" Name="Abnormal pulmonary interstitial morphology" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2917377" TraitType="Finding" MappingType="XRef" MappingValue="HP:0005352" MappingRef="HP">
        <MedGen CUI="C4025208" Name="Severe T-cell immunodeficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2733048" TraitType="Disease" MappingType="XRef" MappingValue="C0796126" MappingRef="MedGen">
        <MedGen CUI="C0796126" Name="Aicardi-Goutieres syndrome 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2917378" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000717" MappingRef="HP">
        <MedGen CUI="C0004352" Name="Autism" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2917377" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000717" MappingRef="HP">
        <MedGen CUI="C0004352" Name="Autism" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2917377" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002015" MappingRef="HP">
        <MedGen CUI="C0011168" Name="Dysphagia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2917377" TraitType="Disease" MappingType="XRef" MappingValue="225750" MappingRef="OMIM">
        <MedGen CUI="C0796126" Name="Aicardi-Goutieres syndrome 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2917378" TraitType="Finding" MappingType="XRef" MappingValue="HP:0005352" MappingRef="HP">
        <MedGen CUI="C4025208" Name="Severe T-cell immunodeficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2733048" TraitType="Disease" MappingType="XRef" MappingValue="C1860518" MappingRef="MedGen">
        <MedGen CUI="C1860518" Name="Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

